<DOC>
	<DOCNO>NCT02052726</DOCNO>
	<brief_summary>This study investigate clostridium difficile vaccine healthy adult age 50 85 year , receive 3 dos vaccine . Subjects receive vaccine dose either month 0 , 1 , 3 day 1 , 8 , 30 . Subjects divide 2 age group ( 50-64 65-85 year age ) . The study ass safe tolerable vaccine , also look subject ' immune response vaccine .</brief_summary>
	<brief_title>A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years , Who Will Each Receive 3 Doses Of Vaccine .</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male female adult age 50 85 year enrollment Proven suspect prior episode Clostridium difficile associate diarrhea . Unstable chronic medical condition disease require significant change therapy hospitalization worsen disease within 8 week receipt study vaccine . Any contraindication vaccination vaccine component , include previous anaphylactic reaction vaccine vaccinerelated component</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>